MELVILLE, N.Y.--(BUSINESS WIRE)--Nov 7, 2023--Henry Schein, Inc. (Nasdaq: HSIC), the world蘑菇视频 largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor ...
CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Nov 7, 2023--Repare Therapeutics Inc. (鈥淩epare鈥� or the 鈥淐ompany鈥�) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced it will host a conference call and live webcast to present the latest data ...
NEW YORK--(BUSINESS WIRE)--Nov 7, 2023--<a ...
BERLIN (AP) 鈥� A German federal court on Tuesday denied two seriously ill men direct access to a lethal dose of a drug, arguing that the country's narcotics law stands in the way and that they could turn to assisted suicide to end their lives.The two men, one of whom has advanced multiple ...
LEXINGTON, Mass.--(BUSINESS WIRE)--Nov 7, 2023--Agenus Inc. (鈥淎genus鈥�) (Nasdaq: AGEN), a leader in discovering and developing novel immunological agents to treat various cancers, today announced results for the third quarter 2023. Agenus executives will host a conference call and webcast at ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov 7, 2023--Sage Therapeutics, Inc. (Nasdaq: SAGE) today reported business highlights and financial results for the third quarter ended September 30, 2023.鈥淚t has been an exciting time at Sage as we prepare for the upcoming commercial launch of ZURZUVAE, ...